{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:52:13Z","timestamp":1790009533306,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To investigate the association of the triglyceride-glucose (TyG) index with severe tubular atrophy\/interstitial fibrosis (T2 lesions) and renal outcomes in patients with IgA nephropathy (IgAN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 1,791 biopsy-proven IgAN patients between October 2014 and September 2024. Receiver operating characteristic (ROC) curve analysis assessed TyG index performance for predicting T2 lesions. Multivariable logistic regression and restricted cubic spline (RCS) models were applied to assess the relationship between the TyG index and T2 lesions. Renal survival was evaluated using Kaplan-Meier analysis and Multivariable Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,791 enrolled IgAN patients, 122 (6.8%) exhibited T2 lesions. The TyG index showed predictive value for T2 lesions (AUC = 0.699, 95%CI: 0.656-0.741), with an optimal cut-off of 8.69 (specificity 64.5%, sensitivity 65.6%). After 1:1 PSM, the high-TyG group (&amp;gt;8.69) had a higher prevalence of severe tubulointerstitial lesions, elevated BMI, serum creatinine, 24-hour urinary protein, lower eGFR (all P &amp;lt; 0.001), and a higher incidence of the primary endpoint (P = 0.020). Multivariable logistic regression confirmed that a high TyG index (TyG&amp;gt;8.69) was independently associated with T2 lesions (OR = 2.365, 95% CI: 1.104-5.062, P = 0.027). RCS analysis indicated a linear dose-response relationship (P for overall&amp;lt;0.001;P for nonlinearity=0.082). Kaplan-Meier analysis showed significantly worse renal survival in the high-TyG group both before and after matching (log-rank=13.59, P&amp;lt;0.001 after matching). Multivariable Cox regression identified a high TyG index as an independent predictor of adverse renal outcomes (HR = 1.561, 95% CI: 1.046\u20132.330, P = 0.029).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The TyG index is independently associated with severe tubulointerstitial damage and poor renal survival in IgAN, with a value &amp;gt;8.69 effectively identifying high-risk patients for progressive renal injury.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1754033","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:48:44Z","timestamp":1769150924000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The triglyceride-glucose index as an independent associate of severe tubulointerstitial fibrosis and a predictor of renal survival in IgA nephropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Guijing","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hangzhou Traditional Chinese Medicine (TCM) Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, Zhejiang, China"]},{"name":"Key Laboratory of Precise Prevention and Treatment of Rheumatism Syndrome of Renal Wind Disease","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in igA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae252","article-title":"Long-term outcomes of IgA nephropathy in China","volume":"40","author":"Shen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-023-03685-z","article-title":"To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients","volume":"56","author":"Saleem","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000000000195","article-title":"Systematic review of the oxford classification of igA nephropathy: reproducibility and prognostic value","volume":"4","author":"Howie","year":"2023","journal-title":"Kidney360"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.22-63","article-title":"Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance","volume":"72","author":"Ramdas Nayak","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","article-title":"Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome","volume":"23","author":"Wei","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2020.09.001","article-title":"Triglyceride-glucose index predicts\u00a0independently type 2 diabetes mellitus risk: A systematic review and meta-analysis of cohort studies","volume":"14","author":"da Silva","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01732-0","article-title":"The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis","volume":"22","author":"Yang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","article-title":"Triglyceride-glucose index and heart failure: a systematic review and meta-analysis","volume":"22","author":"Khalaji","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12933-023-02087-w","article-title":"The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study","volume":"22","author":"Xin","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40200-025-01680-y","article-title":"Association of triglyceride-glucose index with diabetic kidney disease in patients with type 2 diabetes","volume":"24","author":"Siddiqui","year":"2025","journal-title":"J Diabetes Metab Disord"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-01044-5","article-title":"Baseline and usual triglyceride-glucose index and the risk of chronic kidney disease: a prospective cohort study","volume":"46","author":"Kunutsor","year":"2024","journal-title":"Geroscience"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175176","article-title":"Triglyceride-glucose index may predict renal survival in patients with igA nephropathy","volume":"11","author":"Qin","year":"2022","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.234","article-title":"Severity of arterial and\/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis","volume":"7","author":"Sugiura","year":"2021","journal-title":"J Pathol Clin Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1001-7097.2020.02.007","article-title":"The relationship between hemoglobin and renal tubular atrophy\/interstitial fibrosis in patients with IgA nephropathy [in Chinese","volume":"36","author":"Chen","year":"2020","journal-title":"Chin J Nephrol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12882-021-02632-3","article-title":"Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy","volume":"23","author":"Li","year":"2022","journal-title":"BMC Nephrol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s40001-024-02148-0","article-title":"The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is associated with severe renal tubular atrophy\/interstitial fibrosis in IgA nephropathy","volume":"29","author":"Liang","year":"2024","journal-title":"Eur J Med Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e43455","DOI":"10.1097\/MD.0000000000043455","article-title":"Analysis of risk factors for tubular atrophy\/interstitial fibrosis in primary membranous nephropathy","volume":"104","author":"Fang","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-02844-4","article-title":"Hyperuricemia and hypertriglyceridemia indicate tubular atrophy\/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy","volume":"53","author":"Liu","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-8871-2_26","article-title":"Lipid metabolism disorder and renal fibrosis","volume":"1165","author":"Du","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"30996","DOI":"10.1038\/s41598-024-81929-3","article-title":"The impact of metabolic component count on IgA nephropathy prognosis","volume":"14","author":"Ma","year":"2024","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0386","article-title":"Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK\/SIRT1-independent pathway","volume":"60","author":"Kitada","year":"2011","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S0085","DOI":"10.1016\/j.kint.2025.08.030","article-title":"Critical role of transcription factor SOX4 in tubular epithelial cell dedifferentiation and fibroblast activation during kidney fibrosis","volume":"109","author":"Du","year":"2025","journal-title":"Kidney Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113057","article-title":"STAT6 deficiency attenuates myeloid fibroblast activation and macrophage polarization in experimental folic acid nephropathy","volume":"10","author":"Jiao","year":"2021","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17412","article-title":"Genetic deficiency or pharmacological inhibition of cGAS-STING signalling suppresses kidney inflammation and fibrosis","volume":"182","author":"Jiao","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30574","article-title":"Myeloid PTEN deficiency aggravates renal inflammation and fibrosis in angiotensin II-induced hypertension","volume":"237","author":"An","year":"2022","journal-title":"J Cell Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16224","DOI":"10.1038\/s41598-024-65857-w","article-title":"Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy","volume":"14","author":"Tringali","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.91804","article-title":"Development and validation\u00a0of\u00a0a\u00a0diagnostic nomogram to evaluate tubular atrophy\/interstitial fibrosis\u00a0of IgA nephropathy","volume":"21","author":"Gan","year":"2024","journal-title":"Int J Med Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12882-019-1420-0","article-title":"Serum complement C4 is an important prognostic factor for IgA nephropathy: a retrospective study","volume":"20","author":"Bi","year":"2019","journal-title":"BMC Nephrol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.831648","article-title":"Association between the surrogate markers of insulin resistance and chronic kidney disease in chinese hypertensive patients","volume":"9","author":"Shi","year":"2022","journal-title":"Front Med (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1754033\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:31:04Z","timestamp":1771921864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1754033\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1754033"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1754033","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1754033"}}